Trends in the Prevalence of Fetal Macrosomia in the United States, 2004 to 2022.

Globally, the prevalence of macrosomia varies widely, and the trends in macrosomia prevalence are controversial. We aim to analyze temporal changes in fetal macrosomia prevalence from 2004 to 2022.This study included 72,879,544 singleton deliveries from the U.S. National Vital Statistics System Natality Files. We used Joinpoint regression to assess annual trends in fetal macrosomia (birth weight: 4,000 g), further classified into Grade 1 (4,000-4,499 g), Grade 2 (4,500-4,999 g), and Grade 3 (5,000 g).The overall prevalence of fetal macrosomia declined overall from 8.85% (95% CIs: 8.83, 8.88) in 2004 to 7.42% (95% CIs: 7.40, 7.45) in 2022, representing an average annual relative decrease of 0.89% (95% CIs: -1.17%, -0.61%). The temporal trend was nonlinear: a sharp decrease from 2004-2007 (APC: -3.63; 95% CIs: -4.92, -2.32), a modest increase during 2007-2015 (APC: 0.79; 95% CIs: 0.41, 1.16), and a steady decline from 2015-2022 (APC: -1.59; 95% CIs: -1.98, -1.20). Subgroup analyses revealed consistent declines, with more pronounced reductions among women aged > 30 years, those with a college education, primiparous women, and Asian/Pacific Islander mothers. When stratified by severity, the prevalence of Grade 1 macrosomia decreased from 7.53% to 6.42% (AAPC: -0.80; 95% CIs: -1.06, -0.53), Grade 2 decreased from 1.13% to 0.84% (AAPC:-1.50; 95% CIs: -1.94, -1.06), and Grade 3 from 0.20% to 0.16% (AAPC: -0.85; 95% CIs: -1.42, -0.27).The prevalence of fetal macrosomia has varied over time, showing an overall downward trend over the past 20 years, with two periods of rapid decline (2004-2007 and 2015-2022) and one period of moderate increase (2007-2015). The changes observed were significant for Grade 1 and Grade 2 macrosomia, while Grade 3 macrosomia also showed a downward trend, but without distinct segment slopes. · The overall prevalence of fetal macrosomia in the United States declined from 8.85% in 2004 to 7.42% in 2022, with a non-linear trend marked by two periods of decline and one of moderate increase.. · The trend was more pronounced among women aged >30 years, with college education, primiparous women, and Asian/Pacific Islander mothers.. · Severity-stratified analyses revealed significant declines in Grade 1 and Grade 2, while Grade 3 demonstrated a modest decrease without distinct Joinpoint segments..

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-09-16
DOI
https://doi.org/10.1055/a-2696-3320
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends in the Prevalence of Fetal Macrosomia in the United States, 2004 to 2022.

Guodong Ding, Peipei Hu, Angela Vinturache, Chutian Shi et al.
PubMed
Pregnancy and preeclampsia studies
article

Trends in the Prevalence of Fetal Macrosomia in the United States, 2004 to 2022.

Guodong Ding, Peipei Hu, Angela Vinturache, Chutian Shi, Yongjun Zhang
article en

Abstract

Globally, the prevalence of macrosomia varies widely, and the trends in macrosomia prevalence are controversial. We aim to analyze temporal changes in fetal macrosomia prevalence from 2004 to 2022.This study included 72,879,544 singleton deliveries from the U.S. National Vital Statistics System Natality Files. We used Joinpoint regression to assess annual trends in fetal macrosomia (birth weight: 4,000 g), further classified into Grade 1 (4,000-4,499 g), Grade 2 (4,500-4,999 g), and Grade 3 (5,000 g).The overall prevalence of fetal macrosomia declined overall from 8.85% (95% CIs: 8.83, 8.88) in 2004 to 7.42% (95% CIs: 7.40, 7.45) in 2022, representing an average annual relative decrease of 0.89% (95% CIs: -1.17%, -0.61%). The temporal trend was nonlinear: a sharp decrease from 2004-2007 (APC: -3.63; 95% CIs: -4.92, -2.32), a modest increase during 2007-2015 (APC: 0.79; 95% CIs: 0.41, 1.16), and a steady decline from 2015-2022 (APC: -1.59; 95% CIs: -1.98, -1.20). Subgroup analyses revealed consistent declines, with more pronounced reductions among women aged > 30 years, those with a college education, primiparous women, and Asian/Pacific Islander mothers. When stratified by severity, the prevalence of Grade 1 macrosomia decreased from 7.53% to 6.42% (AAPC: -0.80; 95% CIs: -1.06, -0.53), Grade 2 decreased from 1.13% to 0.84% (AAPC:-1.50; 95% CIs: -1.94, -1.06), and Grade 3 from 0.20% to 0.16% (AAPC: -0.85; 95% CIs: -1.42, -0.27).The prevalence of fetal macrosomia has varied over time, showing an overall downward trend over the past 20 years, with two periods of rapid decline (2004-2007 and 2015-2022) and one period of moderate increase (2007-2015). The changes observed were significant for Grade 1 and Grade 2 macrosomia, while Grade 3 macrosomia also showed a downward trend, but without distinct segment slopes. · The overall prevalence of fetal macrosomia in the United States declined from 8.85% in 2004 to 7.42% in 2022, with a non-linear trend marked by two periods of decline and one of moderate increase.. · The trend was more pronounced among women aged >30 years, with college education, primiparous women, and Asian/Pacific Islander mothers.. · Severity-stratified analyses revealed significant declines in Grade 1 and Grade 2, while Grade 3 demonstrated a modest decrease without distinct Joinpoint segments..

PubMed
University of Alberta (CA), Shanghai Jiao Tong University (CN), XinHua Hospital (CN)
Openalex Percentile: Top 69%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.